State of Wisconsin Investment Board’s Unity Biotechnology UBX Stock Holding History

State of Wisconsin Investment Board’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,930	Closed	-$296K	–	2162
2021 Q1	$296K	Hold	4,930	–	–	﹤0.01%	1892
2020 Q4	$258K	Sell	4,930 -350	-7%	-$16.9K	﹤0.01%	1908
2020 Q3	$183K	Buy	5,280 +870	+20%	+$55.1K	﹤0.01%	1916
2020 Q2	$383K	Hold	4,410	–	–	﹤0.01%	1499
2020 Q1	$256K	Buy	4,410 +400	+10%	+$25.2K	﹤0.01%	1535
2019 Q4	$289K	Hold	4,010	–	–	﹤0.01%	1549
2019 Q3	$245K	Buy	4,010 +510	+15%	+$36.1K	﹤0.01%	1482
2019 Q2	$332K	Buy	3,500 +80	+2%	+$6.81K	﹤0.01%	1426
2019 Q1	$277K	Buy	+3,420	New	+$388K	﹤0.01%	1430

Other funds holding UBX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wisconsin Investment Board's UBX Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 4,930 shares — an estimated $296K sold.

State of Wisconsin Investment Board first reported a position in UBX in Q1 2019 and held it in 9 quarters. The position peaked at $383K in Q2 2020. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

State of Wisconsin Investment Board reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 4,930 Unity Biotechnology shares in Q2 2021, an estimated $296K.
State of Wisconsin Investment Board first reported a position in Unity Biotechnology in Q1 2019 and held it in 9 quarters.
State of Wisconsin Investment Board's Unity Biotechnology position peaked at $383K in Q2 2020.
98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.